Information needs of men regarding prostate cancer screening and the effect of a brief decision aid - PubMed (original) (raw)
Clinical Trial
Information needs of men regarding prostate cancer screening and the effect of a brief decision aid
Stacey L Sheridan et al. Patient Educ Couns. 2004 Sep.
Abstract
Background: Little is known about what information affects men's decisions about prostate cancer screening.
Methods: We developed a four-part decision aid about prostate cancer screening and tested it in men, ages 45-85, to determine how the information in each part--(1) the epidemiology of prostate cancer; (2) the PSA test; (3) prostate biopsy and treatment options for prostate cancer; and (4) balance sheets to aid decision-making--affected men's interest in screening.
Results: One hundred eighty-eight men from one general internal medicine clinic participated in our study (response rate 65%). Before the decision aid, 76% were interested in screening; 8% were not; and 16% were undecided. The decision aid increased the proportion of men who knew the advantages (+28%; 95% CI: 21-35) and disadvantages (+55%; 95% CI: 48-63%) of screening. It also increased the proportion who knew enough to make a decision (+24; 95% CI: 16-32%). It did not change men's interest in screening (P = 0.134). Twenty percent of men, however, did change their interest category. Men who were undecided at baseline were more likely to change than those who were interested or not interested. There were no clinically meaningful changes in interest following each component part of the decision aid.
Conclusion: Interest in prostate cancer screening is high and remained high after a 10 min decision aid. The decision aid increased the proportion of men with sufficient information to decide about screening. It also changed 20% of men's interest in screening. Because no single piece of information was influential to decision-making in all men, clinicians may want to tailor information to men's individual needs.
Copyright 2004 Elsevier Ireland Ltd.
Similar articles
- Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E, Hewitson P, Brett J, Bukach C, Evans R, Edwards A, Elwyn G, Cargill A, Austoker J. Watson E, et al. Patient Educ Couns. 2006 Nov;63(3):367-79. doi: 10.1016/j.pec.2006.05.005. Epub 2006 Jul 27. Patient Educ Couns. 2006. PMID: 16875796 Clinical Trial. - The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests.
Schapira MM, VanRuiswyk J. Schapira MM, et al. J Fam Pract. 2000 May;49(5):418-24. J Fam Pract. 2000. PMID: 10836772 Clinical Trial. - What influences men's decision to have a prostate-specific antigen test? A qualitative study.
Rai T, Clements A, Bukach C, Shine B, Austoker J, Watson E. Rai T, et al. Fam Pract. 2007 Sep;24(4):365-71. doi: 10.1093/fampra/cmm033. Epub 2007 Jul 21. Fam Pract. 2007. PMID: 17644829 - Minority issues in prostate disease.
French DB, Jones LA. French DB, et al. Med Clin North Am. 2005 Jul;89(4):805-16. doi: 10.1016/j.mcna.2005.02.003. Med Clin North Am. 2005. PMID: 15925651 Review. - Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
Lim LS, Sherin K; ACPM Prevention Practice Committee. Lim LS, et al. Am J Prev Med. 2008 Feb;34(2):164-70. doi: 10.1016/j.amepre.2007.10.003. Am J Prev Med. 2008. PMID: 18201648 Review.
Cited by
- Decision aids for people facing health treatment or screening decisions.
Stacey D, Lewis KB, Smith M, Carley M, Volk R, Douglas EE, Pacheco-Brousseau L, Finderup J, Gunderson J, Barry MJ, Bennett CL, Bravo P, Steffensen K, Gogovor A, Graham ID, Kelly SE, Légaré F, Sondergaard H, Thomson R, Trenaman L, Trevena L. Stacey D, et al. Cochrane Database Syst Rev. 2024 Jan 29;1(1):CD001431. doi: 10.1002/14651858.CD001431.pub6. Cochrane Database Syst Rev. 2024. PMID: 38284415 Review. - A Web-Based Decision Aid for Informed Prostate Cancer Screening: Development and Pilot Evaluation.
Jung W, Cho IY, Jeon KH, Yeo Y, Jun JK, Suh M, Jeong A, Lee J, Shin DW. Jung W, et al. J Korean Med Sci. 2023 Nov 27;38(46):e360. doi: 10.3346/jkms.2023.38.e360. J Korean Med Sci. 2023. PMID: 38013645 Free PMC article. - Knowledge and Awareness of Screening for Prostate Cancer Risk Factors and Symptoms Among the General Population in Tabuk City, Saudi Arabia.
Shaqran TM, Alanazi RM, Haider AM, Almohammadi AD, Hawsawi HA, Almehmadi SG, Alanaze TB, Al-Qahtani MY, Alshammari KF. Shaqran TM, et al. Cureus. 2023 Oct 4;15(10):e46472. doi: 10.7759/cureus.46472. eCollection 2023 Oct. Cureus. 2023. PMID: 37927627 Free PMC article. - A Review of the Presentation of Overdiagnosis in Cancer Screening Patient Decision Aids.
Housten AJ, Lowenstein LM, Hoffman A, Jacobs LE, Zirari Z, Hoover DS, Stacey D, Pratt G, Bevers TB, Volk RJ. Housten AJ, et al. MDM Policy Pract. 2019 Nov 6;4(2):2381468319881447. doi: 10.1177/2381468319881447. eCollection 2019 Jul-Dec. MDM Policy Pract. 2019. PMID: 35187246 Free PMC article. Review. - Delivering the unexpected-Information needs for PSA screening from Men's perspective: A qualitative study.
Kuss K, Adarkwah CC, Becker M, Donner-Banzhoff N, Schloessler K. Kuss K, et al. Health Expect. 2021 Aug;24(4):1403-1412. doi: 10.1111/hex.13275. Epub 2021 Jun 7. Health Expect. 2021. PMID: 34097797 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous